Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii

Author: Kedzierski L.   Black C.G.   Stowers A.W.   Goschnick M.W.   Kaslow D.C.   Coppel R.L.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.19, Iss.32, 2001-09, pp. : 4661-4668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content